"The beginning of the end of Alzheimer’s disease"FDA approves drug that treats disease, not symptoms

[ad_1]

The FDA has approved a drug to treat Alzheimer’s disease that affects the course of the disease itself, rather than its symptoms. The drug dunanumab slowed cognitive and functional decline by up to 35% and reduced patients’ risk of progressing to the next clinical stage of the disease by up to 39% compared with a placebo.

[ad_2]

Source link